A shortage of intravenous and injectable saline solutions in the United States has now been resolved, U.S. Food and Drug ...

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

A longtime shortage of a type of sterile intravenous saline is now resolved, the Food and Drug Administration announced ...

Fintel reports that on August 4, 2025, Stifel downgraded their outlook for Baxter International (NYSE:BAX) from Buy to Hold. Analyst Price Forecast Suggests 72.35% Upside As of July 17, 2025, the ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

Stifel lowered PT to $25 from $36, and downgraded rating from "Buy". Stifel analysts said that while Baxter has made positive ...

Isolated severe storms were possible from the Brainerd lakes area up to International Falls with the best chance after 3 a.m.

Plus, Texas Health's telehealth award and Baylor's rehab honors.

Baxter International Inc BAX Stock XNYS Rating as of Aug 6, 2025 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Key Metrics Financials Valuation Dividends Ownership ...